The House passed through a unanimous voice vote legislation aimed at revamping the approval process for the Food and Drug Administration.
Lawmakers passed a bill that would let the FDA continue to collect user fees from drug and device makers, with the agency using that revenue to speed up approval of new products.
The bill now heads to the Senate, which could take it up during an extended work period next month. Senate Majority Leader Mitch McConnell decided to postpone the month-long August recess until the third week of the month.
The Senate is expected to vote next week on healthcare reform that would partially repeal Obamacare.
The user fee bill included several provisions aimed at speeding up approval of new drugs or devices.
The current user fee program expires at the end of the federal fiscal year in September. Lawmakers have said they need to approve the bill soon to prevent the FDA from sending layoff notices to employees funded by the user fees.